Literature DB >> 22913977

Ongoing spread of colistin-resistant Klebsiella pneumoniae in different wards of an acute general hospital, Italy, June to December 2011.

C Mammina1, C Bonura, F Di Bernardo, A Aleo, T Fasciana, C Sodano, M A Saporito, M S Verde, R Tetamo, D M Palma.   

Abstract

We describe polyclonal spread of colistin-resistant Klebsiella pneumoniae in an acute general hospital in Italy. Between June and December 2011, 58 colistin-resistant K. pneumoniae isolates were recovered from 28 patients admitted to different wards, but mainly in the intensive care units. All isolates were tested for drug susceptibility and the presence of beta-lactamase (bla) genes. Clonality was investigated by repetitive extragenic palindromic (rep)-PCR and multilocus sequence typing (MLST). Fifty-two isolates had minimum inhibitory concentrations (MICs) for colistin of 6-128 mg/L, carried bla(KPC3) and were attributed to sequence type ST258. The remaining six isolates were susceptible to carbapenems, exhibited MICs for colistin of 3-32 mg/L, and belonged to two different types, ST15 and ST273. Rep-PCR included all isolates in three clusters, one containing all ST258 KPC-3-producing isolates and two containing ST15 and ST273 isolates.Cross-transmission containment measures and intensification of staff and environmental hygiene could not stop the outbreak. Selective pressure and horizontal transmission probably contributed to emergence and spread of three different strains of colistin-resistant K. pneumoniae in the hospital. Strict implementation of the above measures and a wider awareness of the antimicrobial resistance threat are crucial to preserve the last therapeutic options of the multidrug-resistant Gram-negative infections.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22913977

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  51 in total

1.  MgrB inactivation is a common mechanism of colistin resistance in KPC-producing Klebsiella pneumoniae of clinical origin.

Authors:  Antonio Cannatelli; Tommaso Giani; Marco Maria D'Andrea; Vincenzo Di Pilato; Fabio Arena; Viola Conte; Kyriaki Tryfinopoulou; Alkiviadis Vatopoulos; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2014-07-14       Impact factor: 5.191

Review 2.  Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.

Authors:  Laurent Poirel; Aurélie Jayol; Patrice Nordmann
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

3.  An outbreak of colistin-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in the Netherlands (July to December 2013), with inter-institutional spread.

Authors:  V Weterings; K Zhou; J W Rossen; D van Stenis; E Thewessen; J Kluytmans; J Veenemans
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-06-12       Impact factor: 3.267

4.  Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy.

Authors:  C Girmenia; G M Rossolini; A Piciocchi; A Bertaina; G Pisapia; D Pastore; S Sica; A Severino; L Cudillo; F Ciceri; R Scimè; L Lombardini; C Viscoli; A Rambaldi
Journal:  Bone Marrow Transplant       Date:  2014-10-13       Impact factor: 5.483

5.  Characterization of porin expression in Klebsiella pneumoniae Carbapenemase (KPC)-producing K. pneumoniae identifies isolates most susceptible to the combination of colistin and carbapenems.

Authors:  Jae H Hong; Cornelius J Clancy; Shaoji Cheng; Ryan K Shields; Liang Chen; Yohei Doi; Yanan Zhao; David S Perlin; Barry N Kreiswirth; M Hong Nguyen
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

6.  Expansion and evolution of a virulent, extensively drug-resistant (polymyxin B-resistant), QnrS1-, CTX-M-2-, and KPC-2-producing Klebsiella pneumoniae ST11 international high-risk clone.

Authors:  Leonardo Neves Andrade; Lúcia Vitali; Gilberto Gambero Gaspar; Fernando Bellissimo-Rodrigues; Roberto Martinez; Ana Lúcia Costa Darini
Journal:  J Clin Microbiol       Date:  2014-05-07       Impact factor: 5.948

7.  Core genome MLST and resistome analysis of Klebsiella pneumoniae using a clinically amenable workflow.

Authors:  Madiha Fida; Scott A Cunningham; Matthew P Murphy; Robert A Bonomo; Kristine M Hujer; Andrea M Hujer; Barry N Kreiswirth; Nicholas Chia; Patricio R Jeraldo; Heidi Nelson; Nicole M Zinsmaster; Nikhil Toraskar; Weizhong Chang; Robin Patel
Journal:  Diagn Microbiol Infect Dis       Date:  2020-01-21       Impact factor: 2.803

Review 8.  Carbapenemase-producing Enterobacteriaceae.

Authors:  Yohei Doi; David L Paterson
Journal:  Semin Respir Crit Care Med       Date:  2015-02-02       Impact factor: 3.119

Review 9.  [Multiresistant gram-negative bacteria. A bacterial challenge of the twenty-first century].

Authors:  K Schröppel; R Riessen
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-03-13       Impact factor: 0.840

10.  Presence of fimH, mrkD, and irp2 virulence genes in KPC-2-producing Klebsiella pneumoniae isolates in Recife-PE, Brazil.

Authors:  Rita de Cássia Andrade Melo; Emmily Margate Rodrigues de Barros; Noel Guedes Loureiro; Heloísa Ramos Lacerda de Melo; Maria Amélia Vieira Maciel; Ana Catarina Souza Lopes
Journal:  Curr Microbiol       Date:  2014-08-02       Impact factor: 2.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.